TBX1 and colorectal cancer: However, a recent study has shown that CAFs, even without activation of chemotherapeutic agents, promote tumor stemness in colorectal cancer [21], implying that CAFs may prime CRC cells to increase tumor stemness before chemotherapy, and which may thus contribute to therapeutic resistance.